This is a prospective, open-label, single-arm, multicenter, observational, longitudinal study designed to describe the outcomes observed with use of ONGENTYS as adjunctive treatment to LD/CD in treating PDeOE patients. (Opti-on)

Objective

Clinical Trial Details>>

Principal Investigator(s)
Andrew Ridder, MD

Clinical Trial Categories

  • Parkinson’s
  • Neurology/Neurosurgery
Sponsor(s)
Neurocrine Biosciences
Contact
Avera Research Institute at 605-504-3154
or ARI@Avera.org

Location

  • Avera Brain & Spine Institute — Plaza 2
    1301 S Cliff Ave
    Plaza 2, Suite 610
    Sioux Falls, SD 57105
    Main: 605-322-7270
  • Avera Medical Group Neurology — Plaza 2
    1301 S Cliff Ave
    Plaza 2, Suite 506
    Sioux Falls, SD 57105
    Main: 605-504-0100
    Fax: 605-504-0159
  • Avera Research Institute — Sioux Falls
    6001 S Sharon Ave
    Sioux Falls, SD 57108
    Main: 605-504-3154